IO target

Entrez Gene ID Official Symbol Species Alias Names Background
340273 IO target ABCB5alphabeta, EST422562, ABCB5 ATP binding cassette subfamily B member 5
6868 IO target ADAM18, CD156B, CSVP, NISBD, NISBD1, TACE ADAM metallopeptidase domain 17
8754 IO target CORD9, MCMP, MDC9, Mltng ADAM metallopeptidase domain 9
2015 IO target EMR1, TM7LN3 adhesion G protein-coupled receptor E1
284 IO target AGP1, AGPT, ANG1 angiopoietin 1
290 IO target APN, CD13, GP150, LAP1, P150, PEPN alanyl aminopeptidase, membrane
367 IO target AIS8, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM, AR androgen receptor
472 IO target AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 ATM serine/threonine kinase
545 IO target FCTCS, FRP1, MEC1, SCKL, SCKL1 ATR serine/threonine kinase
2583 IO target GALGT, GALNACT, GalNAc-T, SPG26 beta-1,4-N-acetyl-galactosaminyltransferase 1
575 IO target GDAIF; brain-specific angiogenesis inhibitor 1 Angiogenesis is controlled by a local balance between stimulators and inhibitors of new vessel growth and is suppressed under normal physiologic conditions. Angiogenesis has been shown to be essential for growth and metastasis of solid tumors. In order to obtain blood supply for their growth, tumor cells are potently angiogenic and attract new vessels as results of increased secretion of inducers and decreased production of endogenous negative regulators. BAI1 contains at least one 'functional' p53-binding site within an intron, and its expression has been shown to be induced by wildtype p53. There are two other brain-specific angiogenesis inhibitor genes, designated BAI2 and BAI3 which along with BAI1 have similar tissue specificities and structures, however only BAI1 is transcriptionally regulated by p53. BAI1 is postulated to be a member of the secretin receptor family, an inhibitor of angiogenesis and a growth suppressor of glioblastomas [provided by RefSeq, Jul 2008]
332 IO target API4, EPR-1 baculoviral IAP repeat containing 5
682 IO target 5F7, CD147, EMMPRIN, EMPRIN, OK, SLC7A11, TCSF basigin (Ok blood group)
728 IO target C5A, C5AR, C5R1, CD88 complement C5a receptor 1
868 IO target Cbl-b, Nbla00127, RNF56 Cbl proto-oncogene B
933 IO target SIGLEC-2, SIGLEC2 CD22 molecule
29126 IO target B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1 CD274 molecule
80381 IO target 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 CD276 molecule
916 IO target IMD18, T3E, TCRE CD3e molecule
959 IO target CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L CD40 ligand